Holen Sie sich die Stockscreener-App
7.03
0.86%
0.06
Journey Medical Corp Aktie (DERM) Neueste Nachrichten
Journey Medical Corporation (NASDAQ:DERM) Short Interest Up 24.6% in May - MarketBeat
Journey Medical (NASDAQ:DERM) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Wall Street Zen Downgrades Journey Medical (NASDAQ:DERM) to Hold - Defense World
Journey Medical Co. (NASDAQ:DERM) Receives Average Rating of "Buy" from Analysts - MarketBeat
Ping An Good Doctor Revamps Brand and Launches Annual Healthcare Service Brand - Yahoo Finance
Journey Medical (DERM) Highlights Emrosi on National TV | DERM S - GuruFocus
Journey Medical announces Emrosi featured on “The Balancing Act” - TipRanks
Birchtech Strengthens Water Treatment Commercialization Team with Strategic Leadership Appointments - The Manila Times
Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV - Yahoo Finance
44,568 Shares in Journey Medical Co. (NASDAQ:DERM) Acquired by Citadel Advisors LLC - Defense World
Citadel Advisors LLC Takes Position in Mingteng International Co. Inc. (NASDAQ:MTEN) - Defense World
Journey Medical stock soars to 52-week high of $8.25 By Investing.com - Investing.com South Africa
Journey Medical stock soars to 52-week high of $8.25 - Investing.com
Tang Capital Management LLC Buys Shares of 1,725,569 Journey Medical Co. (NASDAQ:DERM) - MarketBeat
Contrasting Amarantus BioScience (OTCMKTS:AMBS) and Journey Medical (NASDAQ:DERM) - Defense World
Q2 EPS Estimates for Journey Medical Reduced by Roth Capital - MarketBeat
Journey Medical Q2 EPS Forecast Decreased by Roth Capital - Defense World
20,455 Shares in Journey Medical Co. (NASDAQ:DERM) Purchased by Dimensional Fund Advisors LP - Defense World
Journey Medical Corporation (NASDAQ:DERM) Q1 2025 Earnings Call Transcript - Insider Monkey
Journey Medical price target lowered to $10 from $10.50 at Alliance Global - TipRanks
Trading Resumes for Journey Medical (DERM) Corp | DERM Stock New - GuruFocus
Fortress Biotech Earnings: Triple Win with $28M Checkpoint Deal, FDA Fast-Track, and Rosacea Drug Launch - Stock Titan
Journey Medical (DERM) Surpasses Q1 Revenue Expectations with Su - GuruFocus
Alliance Global Partners Revises Price Target for Journey Medica - GuruFocus
DERM Stock Trading Halted Due to Volatility | DERM Stock News - GuruFocus
Alliance Global Partners Revises Price Target for Journey Medical (DERM) | DERM Stock News - GuruFocus
Journey Medical Corp SEC 10-Q Report - TradingView
Journey Medical Q1 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Journey Medical Q1 2025 reports revenue beat - Investing.com Australia
Journey Medical reports Q1 EPS (18c) vs. (53c) last year - TipRanks
Earnings call transcript: Journey Medical Q1 2025 reports revenue beat By Investing.com - Investing.com UK
Journey Medical earnings missed by $0.08, revenue topped estimates - Investing.com
Journey Medical Corporation (DERM) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Journey Medical Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Journey Medical Corporation Reports First Quarter 2025 Financial Results - TradingView
Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - The Globe and Mail
What To Expect From Journey Medical Corp (DERM) Q1 2025 Earnings - GuruFocus
Care Transition Startup Kouper Lands $10M in Funding - Healthcare Innovation
Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance
Journey Medical (DERM) to Release Quarterly Earnings on Wednesday - Defense World
Dr. Michael Lebow Scholarship Announces Scholarship to Cultivate Future Medical Leaders - Newsfile
Journey Medical (DERM) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
The Joint Corp. (JYNT) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025 - Stock Titan
Journey Medical (NASDAQ:DERM) Shares Down 1.6%Here's Why - MarketBeat
Top Executives at Journey Medical Corp Make Major Stock Moves! - TipRanks
Journey Medical Co. (NASDAQ:DERM) Shares Sold by Envestnet Asset Management Inc. - Defense World
Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Journey Medical Corp Executives Sell Shares to Cover Tax Obligations - TradingView
Journey Medical Co. (NASDAQ:DERM) Short Interest Up 68.0% in April - MarketBeat
McKesson Careers | The future of health starts with you. - McKesson Careers
Renaissance Technologies LLC Lowers Position in Journey Medical Co. (NASDAQ:DERM) - Defense World
1.32%
0.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):